“How to Get Rich From the Cures on Demand Windfall” With Marc Lichtenfeld’s “Biggest Blockbuster of 2013″

Every biotech-related teaser ad promises that you can make life-changing profits while also curing the world of a dread disease, of course — that’s why we love ’em. But this one’s a little bit different — they are teasing a biotech company that is trying to develop new drugs, but according to the pitch this […]

Healthcare Profits Alert

Premium biotech and healthcare investing newsletter with weekly updates. Founding editor Marc Lichtenfeld previously helmed the Access Group and Firstline Investor Alert, both short-lived medical investing letters. Print this

Tom Gardner’s “#1 stock across the entire Motley Fool universe right now?”

Dozens of folks have been asking me about this latest teaser for “Motley Fool One”, which is yet another Motley Fool service that aims to upgrade folks’ relationship with the Fool — they’ve progressed to running “real money” portfolios in recent years, investing the Fool’s own corporate portfolio, and having more interactive stuff like the […]

Motley Fool ONE

Financial Advisory and planning service from the Motley Fool, broad focus and more advisory than typical newsletters, also includes interviews with pundits across and outside the Fool analyst corps. Print this

“The single most controversial recommendation we’ve ever made…” (Frank Curzio)

Phase 1 Investor is the big kahuna newsletter at Stansberry & Associates, the $5,000 newsletter that they typically discount to $3,000 when sending out promo emails … … and they market this letter so heavily that Gumshoe readers flood our inbox whenever a new Phase 1 teaser ad runs. So … another of their teasers […]

The Spear Report

Market analysis, commentary and specific actionable trading advice for the week ahead, with a Model Portfolio. Print this